协同作用的口服β-乳糖组合用于治疗结核病
Diana H Quan1, Trixie Wang1, Elena Martinez2
1Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006 NSW, Australia.
Journal of applied microbiology
|October 12, 2024
概括
贝塔乳酸抗生素显示出治疗结核病 (TB) 的前景. 将特定的β-乳酸盐与clavulanate结合,证明了协同作用,为应对这一全球健康挑战提出了新的治疗选择.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 构成了全球重大健康负担,由于药物发现的挑战,治疗选择有限.
- 重新利用现有的抗菌药物是扩大结核病治疗可能性的可行策略.
- 在结核病治疗中,β-乳糖胺和β-乳糖酶抑制剂的使用不足.
研究的目的:
- 调查β-乳糖胺在与β-乳糖酶抑制剂结合对抗Mycobacterium结核病的体外活性和协同作用.
- 评估这些组合作为结核病新型治疗策略的潜力.
主要方法:
- 根据特定的标准,选择了七种β-乳糖胺,两种β-乳糖酶抑制剂 (avibactam,clavulanate) 和三种二线结核病药物.
- 在体外对Mycobacterium tuberculosis H37Rv进行检测,使用resazurin测定和殖民地形成单元计数.
- 使用Chou-Talalay和Chou-Martin计算来评估药物协同作用和剂量减少.
主要成果:
- 贝塔-乳活性有所不同,而塞法德罗克西尔是最强的.
- 克拉夫兰酸比阿维巴克坦更有效地增强了β-乳酸活性.
- 对于几个β-乳酸/克拉夫兰酸组合,观察到协同效应,而与二线结核病药物的组合显示出对抗性,但有明显的例外.
结论:
- 贝塔乳和克拉夫兰酸的组合显示出对Mycobacterium tuberculosis的协同活性.
- 这些发现表明,β-乳协同作用可以为结核病治疗提供可行的组合疗法.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
01:26Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
01:28Pneumonia IV: Management
304
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
304
01:29Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
01:28Pulmonary Tuberculosis II
212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212